Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

Pulmonary arterial hypertension (PAH) is a rare form of pulmonary hypertension. It occurs because progressive vascular ...

A recent publication in the International Journal of Cardiology, "Pulmonary artery denervation in pulmonary hypertension: A ...

TYPE 2 diabetes (T2D) and hypertension (HTN) are significant contributors to the development of chronic kidney disease (CKD). Both conditions have been linked to glomerulomegaly and podocyte loss, ...

Three decades of data from the Global Burden of Disease Study were analyzed for trends in global, regional, and national ...

Main pulmonary artery diameter is a prognostic indicator in patients with pulmonary arterial hypertension without congenital heart disease.

CHICAGO -- Adding sotatercept (Winrevair) to the treatment regimen for pulmonary arterial hypertension (PAH) in high-risk ...

Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...

Background: During persistent pulmonary hypertension (PPHN ... We investigated whether serum B-type Natriuretic Peptide (BNP) is a useful biomarker to evaluate the course of PPHN and effectiveness ...